Skip to main content
SpringerLink
Log in

Biodistribution and Radiation Dosimetry of the Serotonin 5-HT6 Ligand [11C]GSK215083 Determined from Human Whole-Body PET

  • Research Article
  • Published:
Molecular Imaging and Biology Aims and scope Submit manuscript

Abstract

Purpose

We measured the whole-body distribution of IV-injected [11C]GSK215083, a new 5-HT6 antagonist PET tracer, as a function of time in adult subjects, in order to determine the radiation exposure.

Procedures

After injection with a single bolus of [11C]GSK215083 (range 330–367 MBq; mean 346 MBq), PET emission data were acquired for approximately 120 min in six subjects (three males and three females). Five organs were identified as exhibiting uptake above background. For these, regions of interest were delineated on emission images, and time–activity curves (TAC) generated. Residence times were calculated as the area under the curve of the TAC, normalized to injected activities and standard values of organ volumes. Dosimetry calculations were then performed using the computer program OLINDA/EXM 1.0.

Results

The mean effective dose averaged over both males and females (±standard deviation) was estimated to be 7.7 ± 1.0 μSv/MBq (male 7.0 ± 0.4; female 8.5 ± 0.6). For the effective dose equivalent, the corresponding values are 7.8 ± 1.2 μSv/MBq (male 6.8 ± 0.5; female 8.9 ± 0.1). The organ receiving the highest dose was the lung, with an average equivalent dose of 25.6 ± 6.9 μSv/MBq (male 20.8 ± 5.6; female 30.4 ± 4.4).

Conclusion

The estimated radiation dose for [11C]GSK215083 is consistent with those for other neuroreceptor ligands labeled with carbon-11. The somewhat higher dose estimate for females compared to males may reflect the difference in observed residence times and representative differences in the male and female phantoms used for dosimetry calculations. Based on conventionally accepted dose limits, [11C]GSK215083 may be used for multiple PET scans in the same subject.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Ruat M, Traiffort E, Arrang JM, Tardivel-Lacombe J, Diaz J, Leurs R et al (1993) A novel rat serotonin (5-HT6) receptor: molecular cloning, localization and stimulation of cAMP accumulation. Biochem Biophys Res Commun 193(1):268–276

    Article  PubMed  CAS  Google Scholar 

  2. Monsma FJ, Shen Y, Ward RP, Hamblin MW, Sibley DR (1993) Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs. Mol Pharmacol 43(3):320–327

    PubMed  CAS  Google Scholar 

  3. Yang G, Qiu C, Zhao H, Liu Q, Shao Y (2006) Expression of mRNA for multiple serotonin (5-HT) receptor types/subtypes by the peripheral blood mononuclear cells of rhesus macaques. J Neuroimmunol 178(1–2):24–29

    Article  PubMed  CAS  Google Scholar 

  4. Stefulj J, Jernej B, Cicin-Sain L, Rinner I, Schauenstein K (2000) mRNA expression of serotonin receptors in cells of the immune tissues of the rat. Brain Behav Immun 14(3):219–224

    Article  PubMed  CAS  Google Scholar 

  5. Bourson A, Borroni E, Austin RH, Monsma FJ, Sleight AJ (1995) Determination of the role of the 5-ht6 receptor in the rat brain: a study using antisense oligonucleotides. J Pharmacol Exp Ther 274(1):173–180

    PubMed  CAS  Google Scholar 

  6. Bourson A, Boess FG, Bös M, Sleight AJ (1998) Involvement of 5-HT6 receptors in nigro-striatal function in rodents. Br J Pharmacol 125(7):1562–1566

    Article  PubMed  CAS  Google Scholar 

  7. Bentley JC, Bourson A, Boess FG et al (1999) Investigation of stretching behaviour induced by the selective 5-HT6 receptor antagonist, Ro 04–6790, in rats. Br J Pharmacol 126(7):1537–1542

    Article  PubMed  CAS  Google Scholar 

  8. Lacroix LP, Dawson LA, Hagan JJ, Heidbreder CA (2004) 5-HT6 receptor antagonist SB-271046 enhances extracellular levels of monoamines in the rat medial prefrontal cortex. Synapse 51(2):158–164

    Article  PubMed  CAS  Google Scholar 

  9. Woolley ML, Bentley JC, Sleight AJ, Marsden CA, Fone KC (2001) A role for 5-ht6 receptors in retention of spatial learning in the Morris water maze. Neuropharmacology 41(2):210–219

    Article  PubMed  CAS  Google Scholar 

  10. Rogers DC, Hagan JJ (2001) 5-HT6 receptor antagonists enhance retention of a water maze task in the rat. Psychopharmacology (Berl) 158(2):114–119

    Article  CAS  Google Scholar 

  11. Perez-García G, Meneses A (2005) Oral administration of the 5-HT6 receptor antagonists SB-357134 and SB-399885 improves memory formation in an autoshaping learning task. Pharmacol Biochem Behav 81(3):673–682

    Article  PubMed  Google Scholar 

  12. Woolley ML, Marsden CA, Fone KCF (2004) 5-ht6 receptors. Curr Drug Targets CNS Neurol Disord 3(1):59–79

    Article  PubMed  CAS  Google Scholar 

  13. Upton N, Chuang TT, Hunter AJ, Virley DJ (2008) 5-HT6 receptor antagonists as novel cognitive enhancing agents for Alzheimer’s disease. Neurotherapeutics 5(3):458–469

    Article  PubMed  CAS  Google Scholar 

  14. Martarello L, Cunningham VJ, Matthews JC, Rabiner E, Jakobsen S, Gee AD (2005) Radiolabelling and in vivo evaluation of [11C]GSK215083 as potential PET radioligand for the 5-HT6 receptor in the porcine brain. J Cereb Blood Flow Metab 25(S1):S598

    Article  Google Scholar 

  15. Parker CA, Cunningham V, Martarello L et al (2008) Evaluation of the novel 5-HT6 receptor radioligand, [11C]GSK-215083 in human. NeuroImage 41(Supplement 2):T20

    Article  Google Scholar 

  16. Wilson AA, DaSilva JN, Houle S (1994) Facile radiolabelling and purification of 2β-[O-11CH3]-carbomethoxy-3β-aryltropanes: radiotracers for the dopamine transporter. J Label Compd Radiopharm 34:759–765

    Article  CAS  Google Scholar 

  17. Wilson AA, Garcia A, Jin L, Houle S (2000) Radiotracer synthesis from [(11)C]-iodomethane: a remarkably simple captive solvent method. Nucl Med Biol 27(6):529–532

    Article  PubMed  CAS  Google Scholar 

  18. Brambilla M, Secco C, Dominietto M, Matheoud R, Sacchetti G, Inglese E (2005) Performance characteristics obtained for a new 3-dimensional lutetium oxyorthosilicate-based whole-body PET/CT scanner with the National Electrical Manufacturers Association NU 2–2001 standard. J Nucl Med 46(12):2083–2091

    PubMed  CAS  Google Scholar 

  19. Defrise M, Kinahan PE, Townsend DW, Michel C, Sibomana M, Newport DF (1997) Exact and approximate rebinning algorithms for 3D-PET data. IEEE Trans Med Imaging 16(2):145–158

    Article  PubMed  CAS  Google Scholar 

  20. Hamill JJ, Hawman EG (1995) Evaluating a frequency–space SPECT reconstruction algorithm. SPIE vol. 2622. Proc Opt Eng Midwest 95:785–791

    Google Scholar 

  21. Watson CC, Newport D, Casey ME, de Kemp RA, Beanlands RS, Schmand M (1997) Evaluation of simulation-base scatter correction for 3D PET cardiac imaging. IEEE Trans Nucl Sci 44(1):90–97

    Article  Google Scholar 

  22. Stabin MG, Sparks RB, Crowe E (2005) OLINDA/EXM: the second-generation personal computer software for internal dose assessment in nuclear medicine. J Nucl Med 46(6):1023–1027

    PubMed  Google Scholar 

  23. van der Aart J, Hallett WA, Rabiner EA, Passchier J, Comley RA (2011) Radiation dose estimates for carbon-11-labelled PET tracers. Nucl Med Biol. 2011 Oct 25.[Epub ahead of print]

  24. ICRP (1991) 1990 Recommendations of the International Commission on Radiological Protection. Ann ICRP 21(1–3):1–201

    Google Scholar 

  25. ICRP (2007) The 2007 Recommendations of the International Commission on Radiological Protection. ICRP Publication 103. Ann ICRP 37(2–4):1–332

    Google Scholar 

  26. ICRP (1991) Radiological Protection in Biomedical Research. A report of Committee 3 adopted by the International Commission on Radiological Protection. Ann ICRP 22(3):1–28, v–xxiv

    Article  Google Scholar 

  27. “Radioactive drugs for certain research uses.” Code of Federal Regulations Title 21, Part 361.1 2011. http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=361.1 Accessed 22 June 2011

Download references

Acknowledgments

The authors would like to gratefully acknowledge the help of the following staff at the CAMH PET center who were instrumental in conducting this piece of work: Peter Bloomfield, Jeannie Fong, Armando Garcia, Winston Stableford, and Min Wong. In addition we would like to acknowledge the support of Jan Passchier of GlaxoSmithKline for the many helpful conversations over the years concerning the role of radiation protection in our research studies.

Conflict of Interest

At the time this work was conducted. RAC, CS, WH, NK, EAR and ML were employees of and owners of stock/options in GlaxoSmithKline. AAW and SH have received grants from GlaxoSmithKline.

Author information

Authors and Affiliations

  1. GlaxoSmithKline Clinical Imaging Centre, Imperial College London, Hammersmith Hospital, Du Cane Road, London, W12 0NN, UK

    Robert A. Comley, Cristian Salinas, William Hallett, Nicholas Keat, Eugenii A. Rabiner & Marc Laruelle

  2. Centre for Addiction and Mental Health, Toronto, ON, M5T-1R8, Canada

    Romina Mizrahi, Irina Vitcu, Alvina Ng, Alan A. Wilson & Sylvain Houle

Authors
  1. Robert A. Comley
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Cristian Salinas
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Romina Mizrahi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Irina Vitcu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Alvina Ng
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. William Hallett
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Nicholas Keat
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Alan A. Wilson
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Eugenii A. Rabiner
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Marc Laruelle
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Sylvain Houle
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Eugenii A. Rabiner.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Comley, R.A., Salinas, C., Mizrahi, R. et al. Biodistribution and Radiation Dosimetry of the Serotonin 5-HT6 Ligand [11C]GSK215083 Determined from Human Whole-Body PET. Mol Imaging Biol 14, 517–521 (2012). https://doi.org/10.1007/s11307-011-0523-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11307-011-0523-1

Key words

Search

Navigation